Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced-stage, relapsed chronic lymphocytic leukaemia

Title
Phase II study of subcutaneous alemtuzumab without dose escalation in patients with advanced-stage, relapsed chronic lymphocytic leukaemia
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 144, Issue 1, Pages 78-85
Publisher
Wiley
Online
2008-11-04
DOI
10.1111/j.1365-2141.2008.07451.x

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started